The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. The metric has seen a significant loss of -48.42% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 34.14%. Over the past 30 days, the price of VERV has fallen by 13.05%. And in the last five days, it has surged by 0.42%.
Verve Therapeutics Inc’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $19.34 on 02/29/24, with the lowest value being $4.30 on 08/14/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of VERV Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Verve Therapeutics Inc’s current trading price is -62.82% away from its 52-week high, while its distance from the 52-week low is 67.02%. The stock’s price range over this timeframe has been between $4.30 and $19.34. The shares of the Healthcare sector company recorded a trading volume of approximately 1.28 million for the day, which was comparatively lower than the average daily volume of 1.42 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Verve Therapeutics Inc (VERV) has experienced a quarterly rise of 28.16% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 644.61M and boasts a workforce of 255 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 5.65, with a change in price of +0.37. Similarly, Verve Therapeutics Inc recorded 1,425,520 in trading volume during the last 100 days, posting a change of +5.43%.
VERV’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for VERV stands at 0.14. Similarly, the long-term debt-to-equity ratio is also 0.12.
VERV Stock Stochastic Average
Verve Therapeutics Inc’s raw stochastic average for the past 50 days is currently at 85.71%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 85.40%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 66.77% and 64.77%, respectively.
